Assets, Current of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
LakeShore Biopharma Co., Ltd. quarterly Assets, Current in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Assets, Current for the quarter ending 31 Mar 2025 was $117,329,971, a 7.8% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Assets, Current in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Assets, Current for the quarter ending 31 Mar 2025 was ¥842,218,000, a 6.7% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)
Assets, Current, Quarterly (CNY)
Assets, Current, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $117,329,971 -$9,966,428 -7.8% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $127,296,399 -$23,463,771 -16% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $150,760,170 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Assets, Current (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥842,218,000 -¥60,949,952 -6.7% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥903,167,952 -¥132,810,712 -13% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥1,035,978,664 +¥271,214,271 +35% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥764,764,393 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.